SELLAS Life Sciences Group, Inc. (FRA:RXK3)
1.286
+0.058 (4.72%)
At close: Nov 28, 2025
10.10% (1Y)
| Market Cap | 199.00M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -22.11M |
| Shares Out | n/a |
| EPS (ttm) | -0.24 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 1,865 |
| Open | 1.286 |
| Previous Close | 1.228 |
| Day's Range | 1.286 - 1.286 |
| 52-Week Range | 0.801 - 2.600 |
| Beta | n/a |
| RSI | 43.05 |
| Earnings Date | Mar 18, 2026 |